A detailed history of Daiwa Securities Group Inc. transactions in Ocugen, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 41,398 shares of OCGN stock, worth $41,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,398
Previous 43,097 3.94%
Holding current value
$41,398
Previous $67,000 38.81%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$0.98 - $1.95 $1,665 - $3,313
-1,699 Reduced 3.94%
41,398 $41,000
Q2 2024

Aug 07, 2024

BUY
$1.18 - $1.98 $50,854 - $85,332
43,097 New
43,097 $67,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $217M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.